Actions
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
5
Neutral
5
Bullish
4
Bearish
36
Neutral
5
Bullish
5
Bearish
31
Neutral
0
Bullish
1
Bearish
31
Neutral
0
Bullish
1
Bearish
31
Neutral
0
Bullish
1
Bearish
31
Neutral
0
Bullish
1
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Abate As Industries Ltd (ABATEAS) is currently trading at 6.70 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Abate AS Industries is a diversified, publicly listed Indian group operating an integrated platform spanning healthcare delivery (specialized eye care), optical retail, education and talent development, and retail operations, with an international presence notably in Bahrain and a stated pipeline of 44 eye hospitals under development. In FY2026 the company reported consolidated revenue of approximately Rs.161.8 crores, a 67% year‑on‑year increase, and profit after tax of around Rs.12.3 crores versus Rs.1.1 crores in FY2025, reflecting a meaningful inflection where growth translated into improved profitability and operating leverage for Abate AS Industries. Management reported positive operating cash flow of about Rs.6.1 crores and a strengthened balance sheet with cash equivalents near Rs.3.5 crores and net worth of approximately Rs.199 crores, which together validate improving cash conversion and provide flexibility for disciplined capex and selective acquisitions. Healthcare currently contributes roughly 22% of consolidated revenue but management targets a long‑term shift to approximately 70–80% healthcare as the core revenue and profitability driver, supported by education‑led talent pipelines, optical services, GCC connectivity, and a plan to deploy near‑term capex prudently to scale the platform. Management is targeting an overall EBITDA margin in the high teens (around 18% to 20%) over the medium term, signaling a focus on margin improvements driven by higher healthcare intensity, utilization gains, operating efficiencies, and selective capacity expansion at Abate AS Industries.
Over the past 52 weeks, Abate As Industries Ltd has traded between a low of ₹6.16 and a high of ₹20.11. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Abate As Industries Ltd has a market capitalization of approximately 105.60. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Abate As Industries Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 8.59 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 105.60 Cr, Abate As Industries Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Abate As Industries Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Abate As Industries Ltd is 8.59. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Healthcare Services
Hospital
106 Cr
Low Risk
8.6
60.9
0.0
0.6
20.11
6.16
Sales CAGR
Profit CAGR
ROE
ROCE